/PRNewswire/ I Peace, Inc. (https://www.ipeace.com) announced that the company has agreed to join the California Institute for Regenerative Medicine s.
/PRNewswire/ I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-based biotech start-up, announced that the company had tripled its capacity to manufacture GMP.
/PRNewswire/ I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-based biotech start-up, announced that its cell manufacturing facility is now listed on the FDA.
ALBANY, N.Y. â While Regeneron Pharmaceuticalsâ East Greenbush plant attracts global interest for making its COVID-19 antibody cocktail consisting of two active pharmaceutical ingredients (APIs), there are several other facilities in the Capital Region that are busy making APIs for other drugs.
In fact, the eight-county region has the most API manufacturers out of New Yorkâs 10 economic development regions, according to a Center for Economic Growth (CEG) analysis of the FDAâs Drug Establishments Current Registration Site (DECRS).
The United States imports many APIs from China, and the Albany College of Pharmacy and Health Sciences (ACPHS) is preparing to help the nation reduce its dependence on these imports through its Center for Biopharmaceutical Education and Training (CBET), which will open in January 2021.